etoposide has been researched along with Glaucoma, Neovascular in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Honavar, SG; Rao, R; Reddy, VP | 1 |
| Leahey, A; Manquez, ME; Meadows, AT; Shields, CL; Shields, JA; Sun, H | 1 |
| Hungerford, JL; Kingston, JE; Madreperla, SA; Plowman, PN | 1 |
3 other study(ies) available for etoposide and Glaucoma, Neovascular
| Article | Year |
|---|---|
Preservation of retinoblastoma group E eyes with neovascular glaucoma using intravenous chemotherapy: risk factors and outcomes.
Topics: Age Factors; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child, Preschool; Etoposide; Eye Enucleation; Female; Follow-Up Studies; Glaucoma, Neovascular; Humans; Infant; Infusions, Intravenous; Intraocular Pressure; Male; Retinal Neoplasms; Retinoblastoma; Retrospective Studies; Risk Factors; Salvage Therapy; Treatment Outcome; Vincristine; Visual Acuity | 2019 |
Resolution of iris neovascularization following chemoreduction of advanced retinoblastoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Female; Fluorescein Angiography; Glaucoma, Neovascular; Humans; Infant; Iris; Neovascularization, Pathologic; Retinal Neoplasms; Retinoblastoma; Vincristine | 2006 |
Results of combined chemotherapy and radiotherapy for advanced intraocular retinoblastoma.
Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child, Preschool; Combined Modality Therapy; Etoposide; Eye Enucleation; Eye Neoplasms; Female; Glaucoma, Neovascular; Humans; Infant; Male; Neoplasm Recurrence, Local; Retinoblastoma; Survival Rate; Vincristine; Visual Acuity | 1996 |